| Trade Names: | |
| Synonyms: | |
| Status: | Approved (2017) |
| Entry Type: | Antibody |
| Molecule Category: | UNKNOWN |
| ATC: | R03DX10 |
| UNII: | 71492GE1FX |
Pharmacology
| Action | Mechanism of Action | Reference |
|---|---|---|
| INHIBITOR | Interleukin-5 receptor subunit alpha inhibitor |
Indications
| Mesh Heading | Maximum Phase | Mesh ID | Reference |
|---|---|---|---|
| Asthma | 4 | D001249 | FDA |
| Hypereosinophilic Syndrome | 3 | D017681 | ClinicalTrials |
| Nasal Polyps | 3 | D009298 | ClinicalTrials |
| Pemphigoid, Bullous | 3 | D010391 | ClinicalTrials |
| Eosinophilic Esophagitis | 3 | D057765 | ClinicalTrials |
| Pulmonary Disease, Chronic Obstructive | 3 | D029424 | ClinicalTrials |
| Sinusitis | 2 | D012852 | ClinicalTrials |
| Dermatitis, Atopic | 2 | D003876 | ClinicalTrials |
| Urticaria | 2 | D014581 | ClinicalTrials |
| Hematologic Diseases | 2 | D006402 | ClinicalTrials |
Adverse Reactions
System Organ Classification (SOC)
Cross References
| Resources | Reference |
|---|---|
| CAS NUMBER | 1044511-01-4 |
| ChEMBL | CHEMBL1742991 |
| FDA SRS | 71492GE1FX |
| Guide to Pharmacology | 7674 |
CONTENTS